Why Oscar Health, Inc.’s (OSCR) Stock Is Up 5.35%
As of Tuesday, July 28, Oscar Health, Inc.’s OSCR share price has surged by 5.35%, which has investors questioning if this is right time to sell.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
Commentary & Analysis
Is Oscar Health, Inc. (OSCR) Overvalued?
We dive into why Oscar Health, Inc. (OSCR) could be considered overvalued on 2026-07-24, based on AAII’s Value Score and Grade.Tudor Pop
Why Oscar Health, Inc.’s (OSCR) Stock Is Up 8.03%
As of Wednesday, July 01, Oscar Health, Inc.’s OSCR share price has surged by 8.03%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Oscar Health, Inc.’s (OSCR) Stock Is Up 10.01%
As of Wednesday, July 01, Oscar Health, Inc.’s OSCR share price has surged by 10.01%, which has investors questioning if this is right time to sell.Jenna Brashear
Which Is a Better Investment, Horace Mann Educators Corporation or Oscar Health, Inc. Stock?
Learn more about whether Horace Mann Educators Corporation or Oscar Health, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Rosalio Madrigal
Financial Summary
| Share Statistics | OSCR | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $9,402.8 | $7,055.8 | 77% |
|
| Shares Out (Mil) | 329.8 | 66.0 | 84% |
|
| Institutional Ownership | 93.2% | 81.8% | 63% |
|
| Float (Mil) | 249.2 | 67.4 | 77% |
|
| Beta | 2.39 | 0.52 | 95% |
|
| Avg Daily Volume (000s) | 4,268 | 186 | 91% |
|
| Price Change (52-week) |
123.0% | 90.4% | 94% |
|
| Growth | OSCR | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 97.3% | 5.6% | 98% |
|
| Net Income (5yr) | (1.7%) | 14.5% | 37% |
|
| EPS (5yr) | 34.6% | 15.6% | 84 |
|
| Dividends (5yr) | 0.0% | 3.8% | 0% |
|
| Cash Flow (5yr) | (22.2%) | (14.5%) | 29% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 10 | 10 | 10 | |
| Current EPS | $0.380 | $1.110 | $1.566 | |
| Month Ago EPS | $0.316 | $1.058 | $1.485 | |
| # Rev Up | 1 | 1 | 1 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | $0.237 | $0.838 | $1.449 | |
| Year/Year Chg | (81.6%) | (165.7%) | (230.7%) | |
| Financials | OSCR | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $13,302 | $5,065 | 87% |
|
| Net Income (TTM) (Mil) | ($39) | $534 | 18% |
|
| EPS (TTM) | ($0.144) | $2.500 | 35% |
|
| Operating Cash Flow (TTM) (Mil) | $2,835 | $499 | 91% |
|
| Net Cash Flow (TTM) (Mil) | $2,569 | $3 | 98% |
|
| Long-Term Debt (Q1) (Mil) | $482 | $844 | 59% |
|
| Enterprise Value (Q1) (Mil) | $4,068 | $7,585 | 59% |
|
| Valuation | OSCR | Industry Median |
Percentile (All Stocks) |
|
| P/B | 5.61 | 1.77 | 81% |
|
| P/E | na | 12.9 | na |
|
| Dividend Yield | 0.0% | 0.9% | 0% |
|
| PEG (5yr hist) | na | 0.5 | na |
|
| Ratios | OSCR | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 17.4% | 33.4% | 17% |
|
| Net Margin | (0.3%) | 9.9% | 31% |
|
| ROA | (0.5%) | 2.7% | 38% |
|
| ROE | (2.6%) | 14.8% | 33% |
|
| Liabilities to Assets | 82.1% | 76.7% | 77% |
|
| F-Score | 3 | 6 | 19% |
|
Passing Stock Screens
As of 7/31/2026, from a list of 60 stock screening strategies,
FACTOR STRATEGY
Est Rev: Top 30 Up
Factors: Earnings Estimates
Introduction to the use of earnings estimates.
| Performance Since Inception: | 21.5% |
| +/- S&P 500: | +14.0 |
GURU STRATEGY
Kirkpatrick Bargain Screen
Factors: Value, Momentum
Investing model outlined in Charles Kirkpatrick's book, Beat the Market: Invest by Knowing What Stocks to Buy and What Stocks to Sell.
| Performance Since Inception: | 6.8% |
| +/- S&P 500: | -0.7 |
